Aspiriant LLC’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,321
Closed -$204K – 355
2025
Q4
$204K Buy
+1,321
New +$198K 0.01% 314
2022
Q2
– Sell
-3,148
Closed -$431K – 296
2022
Q1
$431K Buy
3,148
+1,700
+117% +$225K 0.02% 187
2021
Q4
$204K Buy
+1,448
New +$192K 0.01% 273

Other funds holding XLV

Aspiriant LLC's XLV Position: Q1 2026 in Review

Aspiriant LLC sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2026, closing a stake of 1,321 shares — an estimated $204K sold.

Aspiriant LLC first reported a position in XLV in Q4 2021 and held it in 3 quarters. The position peaked at $431K in Q1 2022. 1,821 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Aspiriant LLC reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2026 after selling out during the quarter.
  • Aspiriant LLC sold 1,321 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $204K.
  • Aspiriant LLC first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2021 and held it in 3 quarters.
  • Aspiriant LLC's State Street Health Care Select Sector SPDR ETF position peaked at $431K in Q1 2022.
  • 1,821 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.